GlassScriptPhysician profile
Mark S Loewen
NPI 1295747319
$451.59
in general payments reported to CMS, 2019-2025
10 companies · $162 in 2025
The $162 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $73.97 · 2020: $39.56 · 2021: $15.54 · 2022: $30.23 · 2023: $16.30 · 2024: $114 · 2025: $162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $274 · Education: $18.09.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $274.20 |
| Education | $18.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $162.01 | 2025 | Absorbatack |
| Tei Biosciences INC | $58.94 | 2019 | |
| Boston Scientific Corporation | $56.94 | 2024 | Spyglass Discover |
| Tela Bio, INC. | $46.53 | 2022-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Smith+Nephew, INC. | $38.95 | 2024 | Grafix Pl |
| Braintree Laboratories, INC. | $19.97 | 2020 | |
| Abbvie INC. | $19.59 | 2020 | |
| Merck Sharp & Dohme LLC | $18.09 | 2024 | Bridion |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.54 | 2021 | |
| Shire North American Group INC | $15.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Loewen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.